# Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis

> **NCT00777816** · PHASE2 · SUSPENDED · sponsor: **XOMA (US) LLC** · enrollment: 18 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** XOMA 052
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00777816
- **Lead sponsor:** XOMA (US) LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2009-02
- **Primary completion:** 2014-10
- **Final completion:** —
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2015-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777816

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777816, "Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis". Retrieved via AI Analytics 2026-08-19 from https://api.ai-analytics.org/clinical/NCT00777816. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*